Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Bilcare ushers into successful execution of nonClonableID™ technology worldwide

Abstract:
Dr. Sam Pitroda releases technology embedded products across various sectors

Bilcare ushers into successful execution of nonClonableID™ technology worldwide

New Delhi | Posted on July 23rd, 2010

Bilcare Technologies, a research and technology leader focused on creating next-generation anti-counterfeiting, security and brand protection solutions, announced successful execution of its nonClonableID™ for the Security, Pharma and Agrochemical sectors with the symbolic hand over of technology embedded products to leading companies viz: Ranbaxy, Panacea Biotec and Mankind in the Pharma and Indofil in the Agrochemical sectors.

During a function held in Delhi, Dr. Sam Pitroda (Adviser to Prime Minister of India in Public Information, Infrastructure and Innovation) and Dr. R Chidambaram (Principal Scientific Adviser to the Government of India) delivered these technology embedded products to the above mentioned company executives. The function also marked the beginning of a strategic relationship between TCIL and Bilcare with Dr.

Pitroda presenting the business memorandum of understanding (MoU) signed between TCIL and Bilcare Ltd. to Mr. R.K Upadhyay, CMD- TCIL and Mr. Mohan Bhandari, CMD- Bilcare Ltd. The alliance will address the diverse needs of security more particularly in Government related projects within and outside of India.

Mr. Mohan Bhandari, Founder, Chairman & Managing Director, Bilcare Limited announced: "We are working to implement this technology for Delhi Police Force. It is also being deployed in leading pharmaceutical and agrochemical companies in India. Internationally, this technology has been accepted by a leading wine producer in USA as well as by the Presidential security force of an Asian country.

Bilcare is about to close a deal with a European consumer product company. On the document security
front, a major trial is underway with a printer manufacturer in USA". Mr. Bhandari further added: "I feel excited about the potential of this great innovation and firmly believe that we finally have a weapon to fight the challenges of counterfeit menace and give brand owners the security they need, which will not only enhance their sales and profit margins but will also provide consumers the peace of mind".

Worldwide counterfeit market is estimated around 500Bn USD, which adversely affects the global citizens in many ways. Bilcare sees its technology as the answer to this global problem. To accomplish this, Bilcare has already started executing projects. The technology is already being used by one of the largest auto component manufacturer in the world and by museums for security of precious art and heritage artifacts. Bilcare is continuously working with its customers to make sure that they get most advanced and customized relevant solutions, which are scalable and cost effective.

The need to address many vexing challenges like tracking and tracing products, enhancing supply chain efficiency and traceability, thwarting grey markets and managing product recalls for instilling confidence in customers are becoming increasingly important. Bilcare's nonClonableID solution promises to enhance the value for the customer by effectively addressing these needs says Himanshu Bhatt, Global Sales Director for Physical Meets Digital Software Solutions Sales for IBM
based in Texas, USA. Mr. Himanshu stated that IBM and Bilcare are opportunistically pursuing prospects in the market place to allow customers derive the value from IBM's established leadership in Smart planet solutions that combines IBM's Product Traceability software solutions with Bilcare nonClonableID™ solution.

Most existing anti-counterfeiting technologies have limitations. Being generic in nature, the counterfeiters are able to figure them out within 9-12 months after deployment of these technologies by the brand owners. However, Bilcare's nonClonableID™ fingerprints are not possible to be copied as even Bilcare cannot duplicate these fingerprints. The unique ability of nonClonableID™ to enable convincing product authentication on a real-time, anytime-anywhere basis along with complete securitization of the supply chain is making it applicable across diverse sectors viz. pharmaceuticals, agrochemicals, automotive, financial and document securitization, fashion & luxury goods, art & heritage and beyond.

####

About Bilcaretech
Bilcare Technologies is a business unit of Bilcare Ltd. - an innovation-led solutions provider that partners with the global pharmaceutical and healthcare industry to improve patient healthcare outcomes. With breakthrough research and development in micro and nanotechnology, Bilcare Technologies has developed a first-of-its-kind technology - nonClonableID™. The solution enables products to be authenticated as they move through the supply chain to the end consumer.

Bilcare Technologies has manufacturing facilities in Singapore and India and application support centers in the UK, Italy and US. It also leverages on the global network of the Bilcare group to provide sales, marketing and implementation support throughout the world. Bilcare is firmly committed to helping its clients accomplish their business goals, whilst protecting their brands against counterfeiting.

For more information, please click here

Contacts:
Jaydip Chowdhury
Phone: +91 20 30257787
Fax: +91 (20) 30257701

Copyright © Bilcaretech

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Law enforcement/Anti-Counterfeiting/Security/Loss prevention

Tiny particles could help verify goods: Chemical engineers hope smartphone-readable microparticles could crack down on counterfeiting April 15th, 2014

Nanosheets and nanowires April 1st, 2014

Anti-counterfeit 'fingerprints' made from silver nanowires March 20th, 2014

TED Selects Nanotech for Branding and Security on 30th Anniversary Conferences: Nanotech and TED collaborate to create a custom security feature using nano-imaging March 17th, 2014

Products

Nanovations Sets new Benchmark in Automotive Windscreen Coating Durability: Nanovations new automotive glass coating Vision Protect, sets new benchmark in glass coating durability March 23rd, 2014

Tawada CleanTech to show fabric duct and eco cool coating in MegaBuild March 21st, 2014

NEI Introduces Self-healing Anti-corrosion Coating for Zinc-Plated and Galvanized Steel March 14th, 2014

Cima NanoTech Announces Commercial Production of its SANTE(R) FS200 Touch Films for Large Format Touch Screens February 19th, 2014

Announcements

MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014

Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014

Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE